Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis
Phase of Trial: Phase IV
Latest Information Update: 01 Dec 2017
At a glance
- Drugs Golimumab (Primary) ; Purines
- Indications Ulcerative colitis
- Focus Adverse reactions
- Acronyms OPAL
- Sponsors Janssen Biotech
- 23 Dec 2016 Status changed from not yet recruiting to recruiting.
- 28 Oct 2016 Planned initiation date changed from 1 Sep 2016 to 1 Dec 2016.
- 09 Sep 2016 Planned initiation date changed from 1 Jul 2016 to 1 Sep 2016.